McDermott + Bull has successfully placed Alan Dye as Vice President of Quality + Regulatory Affairs with Nuance Medical. Alan brings more than two decades of progressive leadership in medical device quality, regulatory strategy, and operations, most recently serving as Senior Director of Regulatory and previously as Vice President of Quality at Medline Industries. His deep expertise in FDA QSR and ISO 13485 compliance, along with a proven ability to lead global post-market surveillance, quality systems, and recall readiness, positions him to make an immediate impact in advancing Nuance’s commitment to product integrity and regulatory excellence.
Since 2022, McDermott + Bull has partnered closely with Nuance Medical to thoughtfully build out its executive leadership team in alignment with the company’s long-term strategy and evolving business needs. This multi-year collaboration has resulted in the successful placement of five senior leaders across key functions.
The partnership began with the placements of Kristy Matus as Vice President of Product Management and Tammy Hicklin-Estabrook as Vice President of Sales in 2022. The following year, Brian Sill joined as Chief Financial Officer, bringing strong financial leadership to the team. In 2024, Nick Harrison stepped into the role of Vice President of Marketing, followed most recently by the appointment of Alan Dye as Vice President of Quality + Regulatory Affairs in 2025, completing a well-rounded and aligned executive team.
Each of these placements reflects Nuance Medical’s commitment to intentional, high-integrity hiring and McDermott + Bull’s disciplined executive search approach. The use of the Topgrading methodology across all five engagements played a vital role in evaluating and aligning candidates not just to the role, but to Nuance’s culture and long-term goals.
Over the course of our multi-year collaboration, Nuance Medical has exemplified a disciplined, high-integrity approach to building a cohesive leadership team. Reflecting on this partnership, President Mark Steel shared, “McDermott + Bull helped me shape the Nuance Medical leadership team that is now driving our company forward. Their process was disciplined and unrelenting, in the best way. Some searches wrapped quickly, others required patience and persistence, but in every case, they brought clarity, structure, and a deep understanding of what success in the role really meant. They were not just filling seats, they were helping build a foundation. I trusted them, and they delivered.”
Nuance Medical, founded in 2013, designs and markets innovative healthcare products and operates in over 50 countries. Headquartered in the U.S., the company serves both B2B and B2C markets through trusted brands like CryoDose and Biodermis, with a focus on wound care, procedural solutions, and topical anesthetics.
Nuance is backed by MD Holdings, a healthcare-focused private equity firm. McDermott + Bull is proud to have built a strong relationship with Managing Partner Dan Henn and supported executive placements across several of the firm’s portfolio companies.
This executive search was completed by McDermott + Bull Managing Partner Paul Gibbons, Principal Brittany Stansfield, and Senior Consultant Jennifer Ness.